Assistant Professor of Medicine, Dana-Farber Cancer Institute

Oncology

Michael Rabin works in the field of Oncology. He went to medical school at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18 in research and 49 in primary care medicine He over the years received 1 awards: "Super Doctor". Michael Rabin is a published physician. He published 12 publications, including: 'Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.' Michael Rabin accepts all Medicare patients.

Publications

---

• Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
• Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung Cancer patients are associated with shorter survival.
• A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung Cancer.
• Feasibility of Using Algorithm-Based Clinical Decision Support for Symptom Assessment and Management in Lung Cancer.
• Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with EGFR TKI.
• Volumetric tumor growth in advanced non-small cell lung Cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: Developing criteria to conti...
• RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0.
• Creating Computable Algorithms for Symptom Management in an Outpatient Thoracic Oncology Setting.
• Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors.
• The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer with EGFR Mutations.
• Tumoral cavitation in patients with non-small-cell lung Cancer treated with antiangiogenic therapy using bevacizumab.

Schools

---

• Joan Sanford I Weill Medical College Of Cornell University

• Bellevue Hospital Nyu School Med

• Beth Israel Deaconess Hospital

Procedures Preformed

---

• Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anemia
• Bladder Cancer
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Super Doctor

Education

---

• NYU School of Medicine
• Weill Cornell Medical College of Cornell University

Hospital

---

• Brigham and Women's Hospital
• Dana-Farber Cancer Institute

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Andrew X. Zhu, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Elgene Lim, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Gerburg M. Wulf, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lakshmi Nayak, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. John Hilton, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter S. Hammerman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Eddy J. Chen, MD This Doctor is OpenDoctor Recommended.
	Dr. Eliezer M. VanAllen, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph P. Eder, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Alison M. Schram, MD This Doctor is OpenDoctor Recommended.
	Dr. Naomi Ko, MD This Doctor is OpenDoctor Recommended.
	Dr. John K. Erban III, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Douglas V. Faller, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Saulius Girnius, MD This Doctor is OpenDoctor Recommended.
	Dr. Adam Lerner, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog